Analyst Ratings For NASDAQ:BLUE – bluebird bio (NASDAQ:BLUE)
Today, SunTrust Banks raised its price target on NASDAQ:BLUE – bluebird bio (NASDAQ:BLUE) to per share.
Some recent analyst ratings include
- 3/28/2018-Canaccord Genuity Reiterated Rating of Buy.
- 3/16/2018-William Blair Reiterated Rating of Buy.
- 3/16/2018-UBS initiated coverage with a Sell rating.
- 3/14/2018-Janney Montgomery Scott initiated coverage with a Neutral rating.
- On 4/12/2018 David Davidson, Insider, sold 3,000 with an average share price of $180.17 per share and the total transaction amounting to $540,510.00.
- On 4/2/2018 David Davidson, Insider, sold 22,000 with an average share price of $167.52 per share and the total transaction amounting to $3,685,440.00.
- On 3/15/2018 Mark Vachon, Director, sold 6,000 with an average share price of $214.38 per share and the total transaction amounting to $1,286,280.00.
- On 3/1/2018 Philip D Gregory, Insider, sold 2,250 with an average share price of $200.00 per share and the total transaction amounting to $450,000.00.
- On 2/2/2018 David Davidson, Insider, sold 4,000 with an average share price of $202.36 per share and the total transaction amounting to $809,440.00.
- On 1/30/2018 Jason Cole, Insider, sold 25,000 with an average share price of $195.91 per share and the total transaction amounting to $4,897,750.00.
- On 1/30/2018 Susanna Gatti High, COO, sold 17,262 with an average share price of $195.91 per share and the total transaction amounting to $3,381,798.42.
Recent Trading Activity for NASDAQ:BLUE – bluebird bio (NASDAQ:BLUE)
Shares of NASDAQ:BLUE – bluebird bio closed the previous trading session at 177.40 up +2.65 1.52% with 179.9499969482422 shares trading hands.